Department of Biomedical Engineering, University Hospital Olomouc, 779 00, Olomouc, Czech Republic.
Department of Neurology, Palacký University, 779 00, Olomouc, Czech Republic.
Sci Rep. 2020 Oct 16;10(1):17529. doi: 10.1038/s41598-020-70297-3.
Diffusion magnetic resonance imaging (dMRI) proved promising in patients with non-myelopathic degenerative cervical cord compression (NMDCCC), i.e., without clinically manifested myelopathy. Aim of the study is to present a fast multi-shell HARDI-ZOOMit dMRI protocol and validate its usability to detect microstructural myelopathy in NMDCCC patients. In 7 young healthy volunteers, 13 age-comparable healthy controls, 18 patients with mild NMDCCC and 15 patients with severe NMDCCC, the protocol provided higher signal-to-noise ratio, enhanced visualization of white/gray matter structures in microstructural maps, improved dMRI metric reproducibility, preserved sensitivity (SE = 87.88%) and increased specificity (SP = 92.31%) of control-patient group differences when compared to DTI-RESOLVE protocol (SE = 87.88%, SP = 76.92%). Of the 56 tested microstructural parameters, HARDI-ZOOMit yielded significant patient-control differences in 19 parameters, whereas in DTI-RESOLVE data, differences were observed in 10 parameters, with mostly lower robustness. Novel marker the white-gray matter diffusivity gradient demonstrated the highest separation. HARDI-ZOOMit protocol detected larger number of crossing fibers (5-15% of voxels) with physiologically plausible orientations than DTI-RESOLVE protocol (0-8% of voxels). Crossings were detected in areas of dorsal horns and anterior white commissure. HARDI-ZOOMit protocol proved to be a sensitive and practical tool for clinical quantitative spinal cord imaging.
弥散磁共振成像(dMRI)在非脊髓型退行性颈椎脊髓压迫症(NMDCCC)患者中显示出良好的应用前景,即无临床表现的脊髓病。本研究旨在提出一种快速多壳 HARDI-ZOOMit dMRI 方案,并验证其在检测 NMDCCC 患者微结构脊髓病中的可用性。在 7 名年轻健康志愿者、13 名年龄匹配的健康对照者、18 名轻度 NMDCCC 患者和 15 名重度 NMDCCC 患者中,该方案提供了更高的信噪比,增强了微结构图谱中白/灰质结构的可视化效果,提高了 dMRI 指标的可重复性,保持了对患者和对照组差异的敏感性(SE = 87.88%),并提高了特异性(SP = 92.31%),与 DTI-RESOLVE 方案(SE = 87.88%,SP = 76.92%)相比。在 56 个测试的微结构参数中,HARDI-ZOOMit 在 19 个参数中产生了显著的患者-对照组差异,而在 DTI-RESOLVE 数据中,仅在 10 个参数中观察到差异,且其稳健性较低。新的标志物白质-灰质扩散梯度显示出最高的分离度。HARDI-ZOOMit 方案检测到的交叉纤维(5-15%的体素)数量多于 DTI-RESOLVE 方案(0-8%的体素),且具有更合理的生理方向。这些交叉纤维在背角和前白质联合区被检测到。HARDI-ZOOMit 方案被证明是一种敏感而实用的临床定量脊髓成像工具。